✦ LIBER ✦

Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate

✍ Scribed by Young Mee Lee; Marshall M Kaplan

Book ID: 119393793
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 57 KB
Volume: 98
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(02)05850-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Colchicine or Methotrexate, With Ursodio

Colchicine or Methotrexate, With Ursodiol, Are Effective After 20 Years in a Subset of Patients With Primary Biliary Cirrhosis

✍ Leung, John; Bonis, Peter A.; Kaplan, Marshall M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 872 KB

Methotrexate improves biochemical tests

Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol

✍ Peter A.L. Bonis; Marshall Kaplan 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 106 KB

A randomized controlled trial of colchic

A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: Ten-year results

✍ Marshall M. Kaplan; Steven Cheng; Lori Lyn Price; Peter A. L. Bonis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

Primary biliary cirrhosis frequently progresses despite treatment with ursodeoxycholic acid (UDCA), the only approved therapy. Previous studies suggested that colchicine and methotrexate may improve biochemical tests of liver function, symptoms, and liver histology. The aim of the present study was

S1274 19-Year Follow-up of Patients in a

S1274 19-Year Follow-up of Patients in a Double-Blind Trial of Colchicine Plus Ursodiol Versus Methotrexate Plus Ursodiol in the Treatment of Primary Biliary Cirrhosis

✍ John Leung; Alan Bonder; Morris Sasson; Peter Bonis; Marshall Kaplan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Treatment with immunosuppressives in pat

Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol

✍ Marshall M. Kaplan; Raoul Poupon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

We wish to add an additional suggestion to the "AASLD Practice Guidelines: Primary Biliary Cirrhosis" that was published last month in HEPATOLOGY 1 and of which we were coauthors. Approximately 40% of patients with primary biliary cirrhosis (PBC) respond incompletely to treatment with ursodiol. Bec

Synthesis of interleukin-1β in primary b

Synthesis of interleukin-1β in primary biliary cirrhosis: Relationship to treatment with methotrexate or colchicine and disease progression

✍ Laurie C. Miller; Dr Archna Sharma; Augusta F. McKusick; Dr Joseph P. Tassoni; C 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 702 KB

Primary biliary cirrhosis (PBC) is a chronic, progressive, cholestatic liver disease. Interleukin-lp (JL-lp) may play a role in the pathogenesis of PBC by contributing to altered immune function and fibrosis. Colchicine or methotrexate has some beneficial effects in the treatment of PBC, and also af